Assessing vascular stiffness to predict risks after a heart attack
Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction
University Hospital, Lille · NCT04058782
This study is testing if measuring blood vessel stiffness can help doctors predict risks for patients who have just had a heart attack.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Lille (other) |
| Locations | 1 site (Lille) |
| Trial ID | NCT04058782 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the impact of peripheral vascular stiffness assessment on risk prediction in patients who have experienced a myocardial infarction. Patients presenting at the University Hospital of Lille within 48 hours of symptom onset will be recruited to assess various clinical, biological, and imaging parameters one month after their heart attack. The study focuses on identifying factors associated with poor prognosis, including the risk of developing diastolic heart failure and recurrence of myocardial infarction. The findings could enhance risk stratification and management strategies for these patients.
Who should consider this trial
Good fit: Ideal candidates are patients who have experienced a myocardial infarction within 48 hours and have a valid French social security number.
Not a fit: Patients with type 2 myocardial infarction or those presenting after 48 hours of symptom onset may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve risk prediction and management for patients recovering from myocardial infarction.
How similar studies have performed: Other studies have shown promise in using vascular stiffness assessments for risk prediction, indicating this approach has potential based on prior findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed informed consent * Affiliated to national health insurance (French social security number) * Presenting with MI within 48 hours of symptom onset Exclusion Criteria: * Patient under curatorship * Type 2 MI * Presenting with MI after 48 hours of symptom onset * Pregnancy or lactating * Refuse to participate * No national health insurance (No French social security number)
Where this trial is running
Lille
- Institut Coeur-Poumon, CHU — Lille, France (RECRUITING)
Study contacts
- Principal investigator: Gilles Lemesle, MD — University Hospital, Lille
- Study coordinator: Gilles Lemesle, MD
- Email: gilles.lemesle@chru-lille.fr
- Phone: 03 20 44 45 61
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Myocardial Infarction, Vascular Stiffness, Heart Failure, Prognosis, Vascular stiffness, Heart failure, Myocardial infarction